Key result
Clinical evidence characterizing the extent, timing, and pattern of endothelial coverage on fluoropolymer-coated left atrial appendage closure devices remains sparse.
Why the study?
Does device position influence healing and endothelialization progression on fluoropolymer-coated left atrial appendage closure devices?
Does device position influence healing and endothelialization progression on fluoropolymer-coated left atrial appendage closure devices?
Answers are grounded in this paper and cite their sources.
Clinical evidence characterizing the extent, timing, and pattern of endothelial coverage on fluoropolymer-coated LAAC devices in humans remains sparse, leaving the clinical relevance of FP-related acceleration unresolved.
The extent of endothelialization of left atrial appendage closure (LAAC) devices is a key determinant of thrombotic risk, particularly device-related thrombus (DRT) formation. Although animal models suggest that fluoropolymer (FP)-coated devices accelerate endothelial coverage and reduce thrombogenicity, clinical evidence remains limited. In particular, human data directly characterizing the extent, timing, and pattern of coverage are sparse, leaving the clinical relevance of FP-related acceleration unresolved.
No takes yet. Share an insight, caveat, or question.
Ogawa et al. (2025) conducted an editorial in Device-related thrombus after left atrial appendage closure. Fluoropolymer-coated left atrial appendage closure devices was evaluated. Clinical evidence characterizing the extent, timing, and pattern of endothelial coverage on fluoropolymer-coated left atrial appendage closure devices remains sparse.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: